Leukemias

Studies related to cancers of the blood including acute lymphocytic leukemia (ALL), chronic lymphocytic leukemia (CLC) (CLL) acute myelogenous leukemia (AML) and chronic myelogenous leukemia (CML).

• Is There an Entity of Chemically Induced BCR-ABL—Positive Chronic Myelogenous Leukemia?
• Therapy Options in Imatinib Failures
• FDA Drug Approval Summary: Alemtuzumab as Single-Agent Treatment for B-Cell Chronic Lymphocytic Leukemia
• Battling the Hematological Malignancies: The 200 Years' War
• Large Granular Lymphocyte Leukemia EXPIRED
• Chronic Lymphocytic Leukemia: Recent Advances in Diagnosis and Treatment EXPIRED
• Practice Points, Consensus, and Controversial Issues in the Management of Patients with Newly Diagnosed Acute Promyelocytic Leukemia EXPIRED
• Arsenic Trioxide (Trisenox®) Therapy for Acute Promyelocytic Leukemia in the Setting of Hematopoietic Stem Cell Transplantation EXPIRED
• Indications for Imatinib Mesylate Therapy and Clinical Management EXPIRED
• Optimizing Treatment of Chronic Myeloid Leukemia: A Rational Approach EXPIRED
• T-Cell Large Granular Lymphocyte Leukemia and Related Disorders EXPIRED
• The Forgotten Myeloproliferative Disorder: Myeloid Metaplasia EXPIRED
• Multifaceted Approach to the Treatment of Bcr-Abl-Positive Leukemias EXPIRED
• New Approaches to the Treatment of Myelodysplasia EXPIRED
• Molecular Targets of Arsenic Trioxide in Malignant Cells EXPIRED
• Advances in the Management of Acute Promyelocytic Leukemia and Other Hematologic Malignancies with Arsenic Trioxide EXPIRED